CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
169 hedge funds and large institutions have $318M invested in Clovis Oncology, Inc. in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
8% more funds holding
Funds holding: 157 → 169 (+12)
3% less capital invested
Capital invested by funds: $328M → $318M (-$9.42M)
Holders
169
Holding in Top 10
2
Calls
$30.1M
Puts
$26.5M
Top Buyers
| 1 | +$10.2M | |
| 2 | +$6.35M | |
| 3 | +$5.83M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.32M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.43M |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$1.48M | |
| 3 | -$1.47M | |
| 4 |
Barclays
London,
United Kingdom
|
-$1.43M |
| 5 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$1.14M |